Showing results (1-10 of 167) with videos related to
Sort By:
Pageof 17
Current Gastroenterology Reports|September 12, 2000
Mesalamine for prophylaxis of small bowel Crohn's disease recurrenceW M Bauer, A Brzezinski, B A LashnerCleveland Clinic Journal of Medicine|September 1, 1995
Use of old and new oral 5-aminosalicylic acid formulations in inflammatory bowel diseaseA Brzezinski, G B Rankin, D L Seidner, et al.The American Journal of Gastroenterology|March 1, 1995
Worsening risk for the development of dysplasia or cancer in patients with chronic ulcerative colitisB A Lashner, K S Provencher, J M Bozdech, et al.The American Journal of Gastroenterology|June 11, 1999
The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitisK Shetty, L Rybicki, A Brzezinski, et al.Gastroenterology|January 1, 1997
The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitisB A Lashner, K S Provencher, D L Seidner, et al.Gastroenterology Clinics of North America|September 1, 1995
Epidemiology of inflammatory bowel diseaseB A LashnerJournal of Cancer Research and Clinical Oncology|January 1, 1993
Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitisB A LashnerCleveland Clinic Journal of Medicine|July 1, 1994
Colorectal cancer in ulcerative colitis patients: survival curves and surveillanceB A LashnerThe American Journal of Gastroenterology|February 1, 1992
Recommendations for colorectal cancer screening in ulcerative colitis: a review of research from a single university-based surveillance programB A LashnerDigestive Diseases and Sciences|August 1, 1992
Risk factors for small bowel cancer in Crohn's diseaseB A LashnerPageof 17